nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—CYP2E1—liver cancer	0.799	1	CbGaD
Dalfampridine—Nasopharyngitis—Sorafenib—liver cancer	0.00124	0.0344	CcSEcCtD
Dalfampridine—Infestation NOS—Sorafenib—liver cancer	0.00107	0.0297	CcSEcCtD
Dalfampridine—Infestation—Sorafenib—liver cancer	0.00107	0.0297	CcSEcCtD
Dalfampridine—Connective tissue disorder—Sorafenib—liver cancer	0.000946	0.0262	CcSEcCtD
Dalfampridine—Angiopathy—Sorafenib—liver cancer	0.000873	0.0242	CcSEcCtD
Dalfampridine—Immune system disorder—Sorafenib—liver cancer	0.000869	0.0241	CcSEcCtD
Dalfampridine—Mediastinal disorder—Sorafenib—liver cancer	0.000867	0.024	CcSEcCtD
Dalfampridine—Mental disorder—Sorafenib—liver cancer	0.000843	0.0233	CcSEcCtD
Dalfampridine—Angioedema—Sorafenib—liver cancer	0.000766	0.0212	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000708	0.0196	CcSEcCtD
Dalfampridine—Anaphylactic shock—Sorafenib—liver cancer	0.000684	0.0189	CcSEcCtD
Dalfampridine—Infection—Sorafenib—liver cancer	0.000679	0.0188	CcSEcCtD
Dalfampridine—Nervous system disorder—Sorafenib—liver cancer	0.000671	0.0186	CcSEcCtD
Dalfampridine—Skin disorder—Sorafenib—liver cancer	0.000664	0.0184	CcSEcCtD
Dalfampridine—Dyspnoea—Sorafenib—liver cancer	0.00061	0.0169	CcSEcCtD
Dalfampridine—Dyspepsia—Sorafenib—liver cancer	0.000602	0.0167	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00059	0.0163	CcSEcCtD
Dalfampridine—Constipation—Sorafenib—liver cancer	0.000585	0.0162	CcSEcCtD
Dalfampridine—Urticaria—Sorafenib—liver cancer	0.000543	0.015	CcSEcCtD
Dalfampridine—Hypersensitivity—Sorafenib—liver cancer	0.000504	0.0139	CcSEcCtD
Dalfampridine—Asthenia—Sorafenib—liver cancer	0.000491	0.0136	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—liver cancer	0.00046	0.0127	CcSEcCtD
Dalfampridine—Dizziness—Sorafenib—liver cancer	0.000452	0.0125	CcSEcCtD
Dalfampridine—Vomiting—Sorafenib—liver cancer	0.000435	0.012	CcSEcCtD
Dalfampridine—Rash—Sorafenib—liver cancer	0.000431	0.0119	CcSEcCtD
Dalfampridine—Dermatitis—Sorafenib—liver cancer	0.000431	0.0119	CcSEcCtD
Dalfampridine—Headache—Sorafenib—liver cancer	0.000428	0.0119	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—liver cancer	0.000425	0.0118	CcSEcCtD
Dalfampridine—Nausea—Sorafenib—liver cancer	0.000406	0.0112	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—liver cancer	0.000396	0.011	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—liver cancer	0.000396	0.011	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—liver cancer	0.000385	0.0107	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—liver cancer	0.000367	0.0101	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—liver cancer	0.000367	0.0101	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—liver cancer	0.000356	0.00986	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—liver cancer	0.00035	0.00967	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—liver cancer	0.000323	0.00895	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—liver cancer	0.000323	0.00893	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—liver cancer	0.000321	0.00889	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—liver cancer	0.000321	0.00887	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—liver cancer	0.000312	0.00862	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—liver cancer	0.0003	0.00829	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—liver cancer	0.000299	0.00826	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—liver cancer	0.000297	0.00823	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—liver cancer	0.000297	0.00821	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—liver cancer	0.000288	0.00798	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—liver cancer	0.000277	0.00767	CcSEcCtD
Dalfampridine—Convulsion—Epirubicin—liver cancer	0.000268	0.00742	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—liver cancer	0.000264	0.0073	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—liver cancer	0.000263	0.00727	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000262	0.00725	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—liver cancer	0.000255	0.00705	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—liver cancer	0.000253	0.00699	CcSEcCtD
Dalfampridine—Infection—Epirubicin—liver cancer	0.000251	0.00695	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—liver cancer	0.000248	0.00687	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—liver cancer	0.000248	0.00686	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—liver cancer	0.000245	0.00679	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—liver cancer	0.000244	0.00675	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—liver cancer	0.000243	0.00673	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000242	0.0067	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—liver cancer	0.000236	0.00654	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—liver cancer	0.000236	0.00652	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—liver cancer	0.000234	0.00647	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—liver cancer	0.000232	0.00643	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—liver cancer	0.000229	0.00635	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—liver cancer	0.000229	0.00633	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—liver cancer	0.000227	0.00629	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—liver cancer	0.000227	0.00628	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—liver cancer	0.000225	0.00624	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—liver cancer	0.000222	0.00616	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—liver cancer	0.000219	0.00605	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000218	0.00604	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—liver cancer	0.000216	0.00598	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—liver cancer	0.000212	0.00585	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—liver cancer	0.00021	0.00581	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—liver cancer	0.000208	0.00577	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—liver cancer	0.000208	0.00576	CcSEcCtD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—liver cancer	0.000207	0.00126	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTA4—liver cancer	0.000207	0.00126	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000207	0.00126	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALDOB—liver cancer	0.000206	0.00125	CbGpPWpGaD
Dalfampridine—Dyspepsia—Doxorubicin—liver cancer	0.000206	0.0057	CcSEcCtD
Dalfampridine—KCNQ3—Axon guidance—KDR—liver cancer	0.000205	0.00125	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KDR—liver cancer	0.000205	0.00125	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTA4—liver cancer	0.000204	0.00124	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000202	0.00559	CcSEcCtD
Dalfampridine—CYP2E1—Biological oxidations—GSTA2—liver cancer	0.000202	0.00123	CbGpPWpGaD
Dalfampridine—Urticaria—Epirubicin—liver cancer	0.000201	0.00556	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—MET—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—HRAS—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—Constipation—Doxorubicin—liver cancer	0.0002	0.00553	CcSEcCtD
Dalfampridine—KCNQ2—Neuronal System—BRAF—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—BRAF—liver cancer	0.0002	0.00122	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—RAF1—liver cancer	0.000199	0.00121	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CRABP1—liver cancer	0.000197	0.0012	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—RAF1—liver cancer	0.000196	0.0012	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTA1—liver cancer	0.000195	0.00119	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ABL1—liver cancer	0.000193	0.00117	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ABL1—liver cancer	0.000193	0.00117	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Doxorubicin—liver cancer	0.000193	0.00533	CcSEcCtD
Dalfampridine—CYP2E1—Biological oxidations—NAT2—liver cancer	0.000193	0.00117	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—NAT2—liver cancer	0.00019	0.00116	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000188	0.00115	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Epirubicin—liver cancer	0.000186	0.00515	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—liver cancer	0.000186	0.00514	CcSEcCtD
Dalfampridine—Asthenia—Epirubicin—liver cancer	0.000181	0.00502	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—HPGDS—liver cancer	0.000181	0.0011	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HPGDS—liver cancer	0.000181	0.0011	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HPGDS—liver cancer	0.000181	0.0011	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—liver cancer	0.000178	0.00109	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Doxorubicin—liver cancer	0.000172	0.00477	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—HPGDS—liver cancer	0.000172	0.00105	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—liver cancer	0.00017	0.00104	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—liver cancer	0.00017	0.00104	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00017	0.00103	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—liver cancer	0.000168	0.00102	CbGpPWpGaD
Dalfampridine—Asthenia—Doxorubicin—liver cancer	0.000168	0.00464	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—MMP2—liver cancer	0.000167	0.00102	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—liver cancer	0.000167	0.00102	CbGpPWpGaD
Dalfampridine—Dizziness—Epirubicin—liver cancer	0.000167	0.00462	CcSEcCtD
Dalfampridine—KCNQ2—Neuronal System—RAF1—liver cancer	0.000167	0.00102	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—RAF1—liver cancer	0.000167	0.00102	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PSMA4—liver cancer	0.000161	0.000984	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PSMA4—liver cancer	0.000161	0.000984	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PSMD10—liver cancer	0.000161	0.000984	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PSMD10—liver cancer	0.000161	0.000984	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PSMD10—liver cancer	0.000161	0.000984	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PSMA4—liver cancer	0.000161	0.000984	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GPX3—liver cancer	0.000161	0.000984	CbGpPWpGaD
Dalfampridine—Vomiting—Epirubicin—liver cancer	0.000161	0.00445	CcSEcCtD
Dalfampridine—Rash—Epirubicin—liver cancer	0.000159	0.00441	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—liver cancer	0.000159	0.00441	CcSEcCtD
Dalfampridine—Headache—Epirubicin—liver cancer	0.000158	0.00438	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—PPARA—liver cancer	0.000157	0.000958	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARA—liver cancer	0.000157	0.000958	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GOT2—liver cancer	0.000157	0.000957	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GOT2—liver cancer	0.000157	0.000957	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GOT2—liver cancer	0.000157	0.000957	CbGpPWpGaD
Dalfampridine—Dizziness—Doxorubicin—liver cancer	0.000155	0.00428	CcSEcCtD
Dalfampridine—CYP2E1—Biological oxidations—HPGDS—liver cancer	0.000154	0.000938	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—liver cancer	0.000154	0.000937	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PSMA4—liver cancer	0.000153	0.000933	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PSMD10—liver cancer	0.000153	0.000933	CbGpPWpGaD
Dalfampridine—Nausea—Epirubicin—liver cancer	0.00015	0.00415	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—GOT2—liver cancer	0.000149	0.000907	CbGpPWpGaD
Dalfampridine—Vomiting—Doxorubicin—liver cancer	0.000149	0.00411	CcSEcCtD
Dalfampridine—KCNQ3—Axon guidance—RAF1—liver cancer	0.000148	0.000902	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—RAF1—liver cancer	0.000148	0.000902	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2E1—liver cancer	0.000148	0.0009	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2E1—liver cancer	0.000148	0.0009	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2E1—liver cancer	0.000148	0.0009	CbGpPWpGaD
Dalfampridine—Rash—Doxorubicin—liver cancer	0.000147	0.00408	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—liver cancer	0.000147	0.00408	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—liver cancer	0.000147	0.000895	CbGpPWpGaD
Dalfampridine—Headache—Doxorubicin—liver cancer	0.000146	0.00405	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—KDR—liver cancer	0.000146	0.00089	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—liver cancer	0.000146	0.00089	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK14—liver cancer	0.000145	0.000885	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK14—liver cancer	0.000145	0.000885	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—liver cancer	0.000143	0.000871	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—liver cancer	0.000143	0.000871	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—liver cancer	0.000143	0.000869	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—liver cancer	0.000143	0.000869	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—liver cancer	0.000143	0.000869	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2E1—liver cancer	0.00014	0.000853	CbGpPWpGaD
Dalfampridine—Nausea—Doxorubicin—liver cancer	0.000139	0.00384	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—HRAS—liver cancer	0.000139	0.000845	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYCS—liver cancer	0.000138	0.000842	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYCS—liver cancer	0.000138	0.000842	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYCS—liver cancer	0.000138	0.000842	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GOT1—liver cancer	0.000136	0.000826	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GOT1—liver cancer	0.000136	0.000826	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GGT1—liver cancer	0.000136	0.000826	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GOT1—liver cancer	0.000136	0.000826	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GGT1—liver cancer	0.000136	0.000826	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GGT1—liver cancer	0.000136	0.000826	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—liver cancer	0.000135	0.000824	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—liver cancer	0.000134	0.000819	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYCS—liver cancer	0.000131	0.000798	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—liver cancer	0.00013	0.000792	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—liver cancer	0.00013	0.000792	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GOT1—liver cancer	0.000129	0.000783	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GGT1—liver cancer	0.000129	0.000783	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—liver cancer	0.000126	0.000766	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—liver cancer	0.000126	0.000766	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—liver cancer	0.000124	0.000753	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—liver cancer	0.000124	0.000753	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—liver cancer	0.000122	0.000742	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—liver cancer	0.000122	0.000742	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—liver cancer	0.000122	0.000742	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—liver cancer	0.000121	0.000739	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—liver cancer	0.00012	0.000732	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—liver cancer	0.00012	0.000732	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—liver cancer	0.00012	0.000732	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—liver cancer	0.000119	0.000727	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—liver cancer	0.000119	0.000727	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000119	0.000724	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—liver cancer	0.000115	0.000703	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—liver cancer	0.000115	0.000703	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GGT1—liver cancer	0.000115	0.000702	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000115	0.000698	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—liver cancer	0.000114	0.000694	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—liver cancer	0.000113	0.000687	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—liver cancer	0.000113	0.000687	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—liver cancer	0.000112	0.000682	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—liver cancer	0.000112	0.000682	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—liver cancer	0.000112	0.000682	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—liver cancer	0.00011	0.000668	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—liver cancer	0.000108	0.000658	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—liver cancer	0.000106	0.000646	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A1—liver cancer	0.000106	0.000646	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1A1—liver cancer	0.000106	0.000646	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A1—liver cancer	0.000106	0.000646	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RAF1—liver cancer	0.000106	0.000644	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RAF1—liver cancer	0.000106	0.000644	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—liver cancer	0.000103	0.00063	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—liver cancer	0.000102	0.000622	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000101	0.000614	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A1—liver cancer	0.000101	0.000613	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—liver cancer	9.96e-05	0.000606	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—liver cancer	9.89e-05	0.000603	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—liver cancer	9.89e-05	0.000603	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—liver cancer	9.89e-05	0.000603	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARA—liver cancer	9.71e-05	0.000591	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARA—liver cancer	9.71e-05	0.000591	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARA—liver cancer	9.71e-05	0.000591	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—liver cancer	9.59e-05	0.000584	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—liver cancer	9.59e-05	0.000584	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—liver cancer	9.51e-05	0.000579	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—liver cancer	9.38e-05	0.000571	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—liver cancer	9.38e-05	0.000571	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARA—liver cancer	9.2e-05	0.00056	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—liver cancer	9.19e-05	0.00056	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—liver cancer	9.19e-05	0.00056	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—liver cancer	9.15e-05	0.000557	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—liver cancer	9.15e-05	0.000557	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A1—liver cancer	9.02e-05	0.000549	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—liver cancer	8.97e-05	0.000546	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—liver cancer	8.97e-05	0.000546	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A1—liver cancer	8.89e-05	0.000542	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—liver cancer	8.64e-05	0.000527	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—RAF1—liver cancer	8.31e-05	0.000506	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—liver cancer	8.31e-05	0.000506	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—liver cancer	8.31e-05	0.000506	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—liver cancer	8.31e-05	0.000506	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—liver cancer	8.16e-05	0.000497	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—liver cancer	8.16e-05	0.000497	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—liver cancer	8.05e-05	0.000491	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—liver cancer	8.05e-05	0.000491	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—liver cancer	8.02e-05	0.000489	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—liver cancer	8.02e-05	0.000489	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—liver cancer	8.02e-05	0.000489	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—liver cancer	7.97e-05	0.000486	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—liver cancer	7.97e-05	0.000486	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—liver cancer	7.88e-05	0.00048	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—liver cancer	7.81e-05	0.000475	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—liver cancer	7.81e-05	0.000475	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—liver cancer	7.6e-05	0.000463	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—liver cancer	7.39e-05	0.00045	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—liver cancer	7.39e-05	0.00045	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—liver cancer	7.31e-05	0.000445	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—liver cancer	7.31e-05	0.000445	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—liver cancer	7.31e-05	0.000445	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—liver cancer	7.21e-05	0.000439	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—liver cancer	7.21e-05	0.000439	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—liver cancer	7.21e-05	0.000439	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—liver cancer	6.98e-05	0.000425	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—liver cancer	6.93e-05	0.000422	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—liver cancer	6.9e-05	0.00042	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—liver cancer	6.9e-05	0.00042	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—liver cancer	6.85e-05	0.000417	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—liver cancer	6.85e-05	0.000417	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—liver cancer	6.84e-05	0.000417	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UGDH—liver cancer	6.74e-05	0.000411	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—liver cancer	6.37e-05	0.000388	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—liver cancer	6.37e-05	0.000388	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—liver cancer	6.37e-05	0.000388	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—EPT1—liver cancer	6.34e-05	0.000386	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—liver cancer	6.04e-05	0.000368	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TAT—liver cancer	6.01e-05	0.000366	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—liver cancer	5.82e-05	0.000354	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—liver cancer	5.82e-05	0.000354	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—liver cancer	5.57e-05	0.000339	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—liver cancer	5.57e-05	0.000339	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—liver cancer	5.14e-05	0.000313	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—liver cancer	5.14e-05	0.000313	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—liver cancer	4.58e-05	0.000279	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLUL—liver cancer	4.09e-05	0.000249	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CPT1B—liver cancer	4.09e-05	0.000249	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NR1H4—liver cancer	3.94e-05	0.00024	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—liver cancer	3.88e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—liver cancer	3.88e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—liver cancer	3.88e-05	0.000236	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA3—liver cancer	3.87e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—liver cancer	3.68e-05	0.000224	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA4—liver cancer	3.54e-05	0.000216	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA2—liver cancer	3.45e-05	0.00021	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA1—liver cancer	3.33e-05	0.000203	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAT2—liver cancer	3.29e-05	0.000201	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—liver cancer	3.17e-05	0.000193	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—liver cancer	3.17e-05	0.000193	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—liver cancer	3.17e-05	0.000193	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDOB—liver cancer	3.16e-05	0.000192	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CRABP1—liver cancer	3.01e-05	0.000183	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—liver cancer	3.01e-05	0.000183	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HPGDS—liver cancer	2.63e-05	0.00016	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PSMA4—liver cancer	2.35e-05	0.000143	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PSMD10—liver cancer	2.35e-05	0.000143	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GOT2—liver cancer	2.28e-05	0.000139	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYCS—liver cancer	2.01e-05	0.000122	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GOT1—liver cancer	1.97e-05	0.00012	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GGT1—liver cancer	1.97e-05	0.00012	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—liver cancer	1.77e-05	0.000108	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—liver cancer	1.75e-05	0.000106	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—liver cancer	1.63e-05	9.91e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A1—liver cancer	1.54e-05	9.39e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—liver cancer	1.44e-05	8.76e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARA—liver cancer	1.41e-05	8.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—liver cancer	1.21e-05	7.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—liver cancer	1.17e-05	7.1e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—liver cancer	1.06e-05	6.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—liver cancer	1.05e-05	6.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—liver cancer	9.25e-06	5.64e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—liver cancer	5.64e-06	3.44e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—liver cancer	4.61e-06	2.81e-05	CbGpPWpGaD
